Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

PERSERIS KIT

RISPERIDONE

Standard Dose
90MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview PERSERIS KIT is listed in Drugs@FDA under application 210655 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient RISPERIDONE Form and strength FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS - 90MG Sponsor INDIVIOR Submission history Latest submission status date: 2025-01-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview PERSERIS KIT is listed in Drugs@FDA under application 210655 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient RISPERIDONE Form and strength FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS - 90MG Sponsor INDIVIOR Submission history Latest submission status date: 2025-01-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.